526 related articles for article (PubMed ID: 30565876)
1. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S; Jatuworapruk K
Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374233
[No Abstract] [Full Text] [Related]
3. Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis.
Bafna P; Sahoo RR; Hazarika K; Manoj M; Rungta S; Wakhlu A
Clin Rheumatol; 2021 Sep; 40(9):3605-3613. PubMed ID: 33686476
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
Feuchtenberger M; Kraus L; Nigg A; Schulze-Koops H; Schäfer A
Rheumatol Int; 2021 Jun; 41(6):1079-1087. PubMed ID: 33608744
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
[TBL] [Abstract][Full Text] [Related]
8. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
[TBL] [Abstract][Full Text] [Related]
9. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis.
Arena U; Stasi C; Mannoni A; Benucci M; Maddali-Bongi S; Cammelli D; Assarat A; Marra F; Pinzani M
Dig Liver Dis; 2012 Feb; 44(2):149-53. PubMed ID: 21930442
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
Frankowski M; Świerkot J; Gomułkiewicz M; Korman L; Skoczyńska M; Starba A
Rheumatol Int; 2022 Apr; 42(4):631-638. PubMed ID: 34870735
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
[TBL] [Abstract][Full Text] [Related]
12. Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.
Laharie D; Seneschal J; Schaeverbeke T; Doutre MS; Longy-Boursier M; Pellegrin JL; Chabrun E; Villars S; Zerbib F; de Lédinghen V
J Hepatol; 2010 Dec; 53(6):1035-40. PubMed ID: 20801541
[TBL] [Abstract][Full Text] [Related]
13. Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
Darabian S; Wade JP; Kur J; Wade SD; Sayre EC; Badii M
J Rheumatol; 2022 Jun; 49(6):558-565. PubMed ID: 35293340
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
15. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
Atallah E; Grove JI; Crooks C; Burden-Teh E; Abhishek A; Moreea S; Jordan KM; Ala A; Hutchinson D; Aspinall RJ; Murphy R; Aithal GP
J Hepatol; 2023 May; 78(5):989-997. PubMed ID: 36702175
[TBL] [Abstract][Full Text] [Related]
16. Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate.
Park SH; Choe JY; Kim SK
Joint Bone Spine; 2010 Dec; 77(6):588-92. PubMed ID: 20471892
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study.
Seitz M; Reichenbach S; Möller B; Zwahlen M; Villiger PM; Dufour JF
Ann Rheum Dis; 2010 Jun; 69(6):1148-50. PubMed ID: 19854710
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound liver elastography for the detection of liver fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy: A cross-sectional study.
Khandpur S; Yadav D; Jangid B; Kumar A; Shalimar ; Devasenathipathy K; Sharma R; Gupta SD; Kumar R; Kalaivani M
Indian J Dermatol Venereol Leprol; 2020; 86(5):508-514. PubMed ID: 32525101
[TBL] [Abstract][Full Text] [Related]
20. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
